BioCentury
ARTICLE | Clinical News

Androderm testosterone patch data

June 16, 1997 7:00 AM UTC

THRT and marketing partner SmithKline Beecham (Philadelphia, Penn.) presented data from clinical trials of Androderm at the Endocrine Society Meeting in Minneapolis.

The 5 mg dose of Androderm applied once per day was found to be bioequivalent to the 2.5 mg dose applied twice per day in a study of 20 hypogonadal men. Cmax values, time to maximum serum concentration, and area under the curve were all equivalent for the two dosing regimens. ...